冻干血浆在院前创伤伤员中的应用:可行性与安全性
该研究为描述性回顾性队列,纳入2013年1月至2016年6月所有在受伤现场及院前接受冻干血浆的109例伤员,描述从受伤现场至出院的伤情、治疗与结局。多数为18至35岁男性,78%为穿透伤,超过半数涉及批量伤员事件,83%接受1单位冻干血浆。57%至少满足一条冻干血浆给药标准,64%需要救命干预。5例(4.6%)出现冻干血浆给药困难,1例女性报告副作用。作者认为该研究支持冻干血浆在受伤现场和院前使用的可行性,但需进一步调整临床实践指南并进一步研究其有效性。
要点
- 109例院前接受冻干血浆的伤员中,83%用1单位、13%用2单位、4%用3单位,9例(8.2%)同时接受院前浓缩红细胞。
- 57%的伤员至少满足一条冻干血浆给药标准,64%需要救命干预,提示院前使用多集中于重伤员。
- 给药困难仅5例(4.6%),副作用仅1例女性报告,支持院前冻干血浆给药的可行性。
- 作者认为需进一步调整临床实践指南,不应仅基于病理生理参数,也应结合临床判断。
- 作者指出需进一步分析现有数据以了解冻干血浆在受伤现场的有效性。
适用人群与场景
- 2013年1月至2016年6月在受伤现场及院前接受冻干血浆的全部伤员,共109例,多数为18至35岁男性。
- 78%为穿透伤,近半数存在多处严重损伤,超过半数涉及批量伤员事件。
诊断标准与关键阈值
- 57%的伤员至少满足一条冻干血浆给药标准。
- 作者认为临床实践指南需调整,不应仅基于病理生理参数,也应结合临床判断。
处置流程与药物剂量
- 在受伤现场及院前给予冻干血浆:83%伤员用1单位,13%用2单位,4%用3单位。
- 9例(8.2%)在院前同时接受浓缩红细胞治疗。
- 64%的伤员需要救命干预。
红旗征与不能漏的情况
- 5例(4.6%)出现冻干血浆给药困难。
- 1例女性伤员报告副作用。
研究设计与关键结果
- 研究类型为描述性回顾性队列研究,样本量109例,人群为2013年1月至2016年6月院前接受冻干血浆的伤员,无对照组。
- 83%用1单位冻干血浆,13%用2单位,4%用3单位;9例(8.2%)同时接受院前浓缩红细胞。
- 57%至少满足一条冻干血浆给药标准,64%需要救命干预。
- 5例(4.6%)出现给药困难,1例女性报告副作用。
证据类型、等级与局限
- 证据类型为回顾性病例系列研究,证据等级为level IV。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为该研究支持冻干血浆在受伤现场和院前使用的可行性。
- 作者认为需进一步调整临床实践指南,不应仅基于病理生理参数,也应结合临床判断。
- 作者指出需进一步分析现有数据以了解冻干血浆在受伤现场的有效性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Hemorrhage is the leading cause of possible preventable death in the battlefield. There is an increasing evidence for the effectiveness of blood component therapy in general, and plasma infusion in particular but their use is less applicable in the prehospital setting due to logistic difficulties. Israeli Defense Force has implemented the use of freeze-dried plasma (FDP) at the point of injury (POI), this adoption of FDP use entailed doubts regarding the feasibility and effectiveness of this practice. In this article, we present our experience with the use of FDP at the POI and prehospital setting regarding the feasibility, safety, adverse reactions, and adherence to clinical practice guidelines.
METHODS: This is a descriptive retrospective cohort study based on all casualties receiving FDP during January 2013 to June 2016. The study describes the injury, treatment, and outcome characteristics from POI until hospital discharge.
RESULTS: During the study period, 109 casualties received FDP. The majority were men, aged 18 years to 35 years. Multiple severe injuries were found in almost half of the casualties, 78% had penetrating injury, and more than half were involved in a multicasualty event. Eighty-three percent were treated with one unit of FDP, 13% with two units, and 4% casualties with three units, nine patients (8.2%) were also treated in the prehospital setting with packed red blood cells. Fifty-seven percent fulfilled at least one criterion for the administration of FDP. Lifesaving interventions were required in 64%. In five (4.6%) cases, there were difficulties with FDP administration. Side effects were reported in one female patient.
CONCLUSION: This study supports the usage feasibility of FDP at the POI and in the prehospital setting. Further adjustment of the clinical practice guidelines is required basing it not only on pathophysiologic parameters but also on clinical judgment. Further investigation of the available data is required to learn about the effectiveness of FDP at POI.
LEVEL OF EVIDENCE: Retrospective case series study, level IV.
参考来源
- Shlaifer A, Siman-Tov M, Radomislensky I, et al. Prehospital administration of freeze-dried plasma, is it the solution for trauma casualties? J Trauma Acute Care Surg. 2017. PMID: 28930960. doi:10.1097/TA.0000000000001569
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。